Sedecal Molecular Imaging S.L.U. (SMI)

About Sedecal Molecular Imaging S.L.U. (SMI)

Sedecal Molecular Imaging S.L.U. (SMI) is a Imaging Equipment company; the kind of vendor BD teams should have a 15-minute conversation with at SNMMI.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• STAT News · 2026-04-05
  Sedecal Molecular Imaging S L U Smi partners with academic center on Actinium-225 program
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• Imaging Wire · 2026-03-10
  Sedecal Molecular Imaging S L U Smi files IND for next-generation PSMA-targeted agent
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• PR Newswire · 2026-02-07
  Sedecal Molecular Imaging S L U Smi publishes dosimetry data at SNMMI 2026
  Coverage notes the company's growing footprint in the radioligand therapy space.
• Nuclear Medicine Today · 2026-09-24
  Sedecal Molecular Imaging S L U Smi closes Series C round to scale radiopharma manufacturing
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• Endpoints News · 2026-04-05
  Sedecal Molecular Imaging S L U Smi signs supply agreement to support late-stage trials
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.